Title : Sorafenib induces renal cell carcinoma apoptosis via upregulating activating transcription factor 4.

Pub. Date : 2018 Mar 5

PMID : 29544563






10 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Sorafenib induces renal cell carcinoma apoptosis via upregulating activating transcription factor 4. Sorafenib activating transcription factor 4 Homo sapiens
2 However, whether sorafenib improves renal cell carcinoma (RCC) through activating transcription factor 4 (ATF4) has never been explored. Sorafenib activating transcription factor 4 Homo sapiens
3 However, whether sorafenib improves renal cell carcinoma (RCC) through activating transcription factor 4 (ATF4) has never been explored. Sorafenib activating transcription factor 4 Homo sapiens
4 Furthermore, sorafenib is demonstrated to enhance the mRNA and protein levels of ATF4. Sorafenib activating transcription factor 4 Homo sapiens
5 More importantly, silencing of ATF4 could largely abolish sorafenib-induced upregulation of CHOP and PUMA in ACHN cells. Sorafenib activating transcription factor 4 Homo sapiens
6 Meanwhile, sorafenib-induced cell apoptosis may be dependent on the activation of ATF4 since knockdown of ATF4 partially reversed sorafenib-induced ACHN cell apoptosis. Sorafenib activating transcription factor 4 Homo sapiens
7 Meanwhile, sorafenib-induced cell apoptosis may be dependent on the activation of ATF4 since knockdown of ATF4 partially reversed sorafenib-induced ACHN cell apoptosis. Sorafenib activating transcription factor 4 Homo sapiens
8 Meanwhile, sorafenib-induced cell apoptosis may be dependent on the activation of ATF4 since knockdown of ATF4 partially reversed sorafenib-induced ACHN cell apoptosis. Sorafenib activating transcription factor 4 Homo sapiens
9 Meanwhile, sorafenib-induced cell apoptosis may be dependent on the activation of ATF4 since knockdown of ATF4 partially reversed sorafenib-induced ACHN cell apoptosis. Sorafenib activating transcription factor 4 Homo sapiens
10 In summary, the present study demonstrates that sorafenib activates ATF4-CHOP-PUMA pathway in RCC cells, resulting in enhanced ER stress-related cell apoptosis. Sorafenib activating transcription factor 4 Homo sapiens